G

GlycoMimetics
D

GLYC

0.25740
USD
-0.00
(-1.00%)
مغلق
حجم التداول
1,099
الربح لكل سهم
-0
العائد الربحي
-
P/E
-0
حجم السوق
16,610,782
أصول ذات صلة
    ALNY
    ALNY
    1.73
    (0.65%)
    266.69 USD
    C
    CRBP
    -0.620
    (-5.18%)
    11.350 USD
    G
    GLMD
    -0.09000
    (-3.08%)
    2.83000 USD
    G
    GLYC
    -0.00260
    (-1.00%)
    0.25740 USD
    P
    PRQR
    0.00000
    (0.00%)
    2.23000 USD
    R
    RGNX
    0.28500
    (3.77%)
    7.85000 USD
    VRTX
    VRTX
    0.08
    (0.02%)
    428.09 USD
    المزيد
الأخبار المقالات

العنوان: GlycoMimetics

القطاع: Healthcare
الصناعة: Biotechnology
GlycoMimetics Inc is a clinical-stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it play in inflammation, cancer, and infection.